BioCentury
ARTICLE | Financial News

Neurodegeneration play Rheostat raises $23M series A

November 27, 2018 12:06 AM UTC

Rheostat Therapeutics (Cambridge, Mass.) raised $23 million in a series A round to bring its first programs in neurodegenerative disease to IND.

The round was co-led by MRL Ventures Fund and AbbVie Ventures, with participation from new investors Amgen Ventures, Alexandria Venture Investments and Mayo Clinic as well as existing investors SV Health Investors and the Dementia Discovery Fund. This year, the company was spun out of SV Health, which seeded the company along with the Dementia Discovery Fund...